99% LORCASERIN CAS: 616202-92-7 For Weight Loss
Contact info :
Email : linda@xrdchem.cn
WhatsApp number : +8618874586545
Wickr : lindayang
Lorcaserin is a new drug for the treatment of obesity , belonging to oral potent selective serotonin 2C receptor agonists, lorcaserin hydrochloride is successfully developed by the US company Arena, on June 27, 2012 by the US FDA it is approved for marketing, as adjuvant therapy for obesity or merge with at least one weight-related complications in overweight adults in low-calorie diet and exercise basis . Clinical studies show that the drug can reduce weight of obesity and overweight patients ,it can improve obesity-related metabolic parameters, and it is well tolerated. Lorcaserin affinity for the 5-HT2c 100 times higher than the 5-HT2B (valvular heart disease risk) ,it has good safety,it is the first FDA-approved weight-loss drug after 1999 . In a year of Lorcaserin treatment, the average weight loss ranges from 3 to 3.7 percent.
| Product Name: | LORCASERIN |
| Synonyms: | Apd 356;Apd356;Apd-356;Ar-10a;Unii-637E494o0z;LORCASERIN;(R)-8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine;APD 356;APD356;APD-356;AR-10A;APD-356;APD 356;APD356 |
| CAS: | 616202-92-7 |
| MF: | C11H14ClN |
| MW: | 195.69 |
| EINECS: | 809-254-4 |
| Product Categories: | Amines;Aromatics;Chiral Reagents;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals |
| Mol File: | 616202-92-7.mol |
China
